An 80-year-old's blood cells were made 60 years 'younger' in a dish. A dish result is a dish result.

Researchers at the University of Bonn announced today, in Aging Cell, that they had converted blood-cell precursors from an 80-year-old donor directly into neural stem cells and watched the cells' epigenetic age — the DNA-methylation clock reading — fall to under 20 years over roughly 100 days in culture. The method skips the embryonic-like intermediate step that makes full reprogramming risky, and the rejuvenation happened gradually enough to track. The preprint reports donors from infancy to 101 and small group sizes. It is careful, publicly funded, European work, and it is the kind of result that will be on a product page by next week as "scientists reverse aging by 60 years." So, the question.

Dish. No animal was treated; no person was treated. Cells were taken out of a body, chemically converted into a different cell type and measured by a clock in a flask. Several things follow. A clock reading in cultured cells is not the age of a person, or even of a tissue. The cells that got "younger" are no longer blood cells; they are neural stem cells, which is the point for researchers studying brain disease and beside the point for anyone hoping to be made younger. Whether such cells could ever be returned to a brain safely is a separate decade of work. This is exactly where the reprogramming story should be — in culture, with its numbers published and its limits stated — and exactly where the consumer market pretends it is not.

Loree’s take

I am asked, several times a month, about products with "cellular rejuvenation" on the label. Here is the actual state of cellular rejuvenation: an experiment in a flask, in Bonn, with cells that are no longer the type they started as, measured by a clock that two studies this summer said is one instrument among several. It is good science. It is not a thing you can be given, and anyone selling it to you has mistaken a petri dish for a patient.

Ben’s take

Track the supply chain of a headline. A university press release says cells were made sixty years younger; a news aggregator drops the word cells; a supplement company screenshots the aggregator. By the third step the dish has become a person and the person has become a customer. The defense is the question in our column's name, asked at every step. Today the answer is dish, and dish is where it will stay for years.

Why it matters to a recovering optimizer. Reprogramming is the most exciting idea in aging biology and, this year, the most borrowed word in aging marketing. The January trial clearance in the eye, the June valuation of a reprogramming company, and this flask in Bonn are the real timeline: human safety trials beginning, biology advancing in culture, benefit unproven everywhere. Nothing on that timeline is for sale. Everything using its vocabulary is.